These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4103779)

  • 21. [Trial evaluation of the therapeutic value of the ovulation inhibitors in seborrhea and acne vulgaris].
    Aron-Brunetière R; Robin J
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(1):47-51. PubMed ID: 4234130
    [No Abstract]   [Full Text] [Related]  

  • 22. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
    Schindler AE
    Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
    Jacobs C; Heinen G; Schmal E
    Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oral treatment of prolonged dysfunctional bleedings with estrogen-gestagen preparations].
    Rehsteiner HP
    Zentralbl Gynakol; 1969 Feb; 91(6):178-86. PubMed ID: 5405176
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of the preparation dl-13-ethyl-17-alpha-ethinyl-17-beta-hydroxy-4-gonen-3-on (WY 3707) in combination with ethinyl estradiol in gynecologic treatment and contraception].
    Misinger I; Krobová I; Moravcová V
    Cesk Gynekol; 1968 Jun; 33(5):329-32. PubMed ID: 5662271
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effects of oral contraceptives on male-pattern alopecia, seborrhoea, acne vulgaris and hirsutism. Anamnestic study on 325 women].
    Hoffmann E; Meiers HG; Hubbes A
    Dtsch Med Wochenschr; 1974 Oct; 99(43):2151-4, 2157. PubMed ID: 4139008
    [No Abstract]   [Full Text] [Related]  

  • 28. NEW ORAL CONTRACEPTIVE: SEQUENTIAL ESTROGEN AND PROGESTIN.
    GOLDZIEHER JW; BECERRA C; GUAL C; LIVINGSTON NB; MAQUEO M; MOSES LE; TIETZE C
    Am J Obstet Gynecol; 1964 Oct; 90():404-11. PubMed ID: 14212801
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic effect after oral gestagens in a case of adrenogenital syndrome].
    Gitsch E
    Zentralbl Gynakol; 1970 Jul; 92(27):867-9. PubMed ID: 5497103
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the use of estroprogestinics in the control of lactation].
    Malato M
    Arch Ostet Ginecol; 1969; 74(5):381-9. PubMed ID: 5408023
    [No Abstract]   [Full Text] [Related]  

  • 31. Preliminary evaluation of four oral contraceptives containing only progestogens.
    Mears E; Vessey MP; Andolsek L; Oven A
    Br Med J; 1969 Jun; 2(5659):730-4. PubMed ID: 4182352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [1st results with the ethynodiol diacetate-mestranol combination].
    Mancuso S
    Minerva Ginecol; 1966 Apr; 18(8):433-7. PubMed ID: 5920234
    [No Abstract]   [Full Text] [Related]  

  • 33. [On modern estrogen therapy].
    Resen Clin Cient; 1968; 37(1):21-5. PubMed ID: 4320014
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of megestrol acetate and ethinyl estradiol in the therapy of dysfunctional metrorrhagia].
    Caldana PL; Barbara A; Carnevale-Arella E
    Quad Clin Ostet Ginecol; 1968 Aug; 23(8):679-89. PubMed ID: 5746114
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sequentaial treatment: estrogen-progestational agents in menstruation disorders].
    Bernard I; Denis JC
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):289-93. PubMed ID: 5711739
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
    Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of cyclofarlutal in gynecological treatments].
    Albano V; Cittadini E; Quartararo P
    Minerva Ginecol; 1966 Nov; 18(22):1247-52. PubMed ID: 6011796
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of dysfunctional bleeding].
    Schneider W
    Wien Med Wochenschr; 1972 Mar; 122(11):147-50. PubMed ID: 5047082
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of selected estrogens and progestins on human chromosomes in vitro.
    Stenchever MA; Jarvis JA; Kreger NK
    Obstet Gynecol; 1969 Aug; 34(2):249-51. PubMed ID: 4183817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.